C. Kityo
Impact in
-
- HIV Research and Treatment
-
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS drug development and treatment 2
- HIV/AIDS Research and Interventions 2
- Parvovirus B19 Infection Studies 1
-
- Immunodeficiency and Autoimmune Disorders 2
C. Kityo
5 papers receiving 19 citations
Peers
Comparison fields: 5 of 11
- Virology 14
- Infectious Diseases 20
- Emergency Medicine 3
- Hepatology 1
- Safety Research 1
Countries citing papers authored by C. Kityo
This map shows the geographic impact of C. Kityo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Kityo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Kityo more than expected).
Fields of papers citing papers by C. Kityo
This network shows the impact of papers produced by C. Kityo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Kityo. The network helps show where C. Kityo may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Kityo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Emergence and evolution of drug resistance in the absence of viral load monitoring during 48 weeks of Combivir/Tenofovir within the DART Trial. | 2007 | 8 |
| 2 | Impact of routine laboratory monitoring over 5 years after antiretroviral therapy (ART)initiation on clinical disease progression of HIV-infected African adults: the DART Trial finalresults | 2009 | 8 |
| 3 | Pregnancy and pregnancy outcome among women in the DART trial. | 2007 | 3 |
| 4 | Discordance between virological/immunological and clinical outcomes at 48 weeks, in a randomised comparison of ZDV/3TC/NVP and ZDV/3TC/ABC in patients with low CD4 counts in Africa. | 2007 | 1 |
| 5 | Superior virological suppression with nevirapine/zidovudine/lamivudine versus abacavir/zidovudine/lamivudine without evidence of clinical benefit to 48 weeks: a randomised comparison in patients with low CD4 counts in Africa. | 2007 | 1 |
| 6 | Immune restoration over 5 years on ART among patients initiating treatment with advanced immune deficiency in the DART trial in Uganda and Zimbabwe. | 2010 | 0 |
About C. Kityo
C. Kityo is a scholar working on Infectious Diseases, Immunology, Hepatology, Virology and Oncology, having authored 6 papers that have together received 21 indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (2 papers), Hepatitis C virus research (2 papers), HIV/AIDS drug development and treatment (2 papers), HIV/AIDS Research and Interventions (2 papers), Adolescent and Pediatric Healthcare (1 paper), HIV Research and Treatment (1 paper), Blood groups and transfusion (1 paper) and Parvovirus B19 Infection Studies (1 paper). The work is most often cited by research in Virology (14 citations), Infectious Diseases (20 citations), Emergency Medicine (3 citations), Hepatology (1 citation) and Safety Research (1 citation). Frequent co-authors include Charles F. Gilks, Paula Munderi, Andrew Reid, Peter Mugyenyi, Deenan Pillay, Val J. Robertson, James Hakim, Elly Katabira, A Babiker and Heiner Grosskurth.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.